J. Craig Venter Institute, 9605 Medical Center Drive, Rockville, Maryland 20850, United States.
J. Craig Venter Institute, 4120 Capricorn Lane, La Jolla, California 92037, United States.
ACS Infect Dis. 2020 Aug 14;6(8):2120-2129. doi: 10.1021/acsinfecdis.0c00196. Epub 2020 Aug 2.
Identifying the mode of action (MOA) of antibacterial compounds is the fundamental basis for the development of new antibiotics, and the challenge increases with the emerging secondary and indirect effect from antibiotic stress. Although various omics-based system biology approaches are currently available, enhanced throughput, accuracy, and comprehensiveness are still desirable to better define antibiotic MOA. Using label-free quantitative proteomics, we present here a comprehensive reference map of proteomic signatures of under challenge of 19 individual antibiotics. Applying several machine learning techniques, we derived a panel of 14 proteins that can be used to classify the antibiotics into different MOAs with nearly 100% accuracy. These proteins tend to mediate diverse bacterial cellular and metabolic processes. Transcriptomic level profiling correlates well with protein expression changes in discriminating different antibiotics. The reported expression signatures will aid future studies in identifying MOA of unknown compounds and facilitate the discovery of novel antibiotics.
鉴定抗菌化合物的作用模式(MOA)是开发新抗生素的基础,随着抗生素压力产生的二次和间接效应的出现,这一挑战日益增加。尽管目前有各种基于组学的系统生物学方法,但为了更好地定义抗生素 MOA,仍需要提高通量、准确性和全面性。本研究采用无标记定量蛋白质组学方法,呈现了在 19 种单一抗生素作用下的蛋白质组特征的综合参考图谱。通过应用几种机器学习技术,我们得出了一个由 14 种蛋白质组成的面板,可用于将抗生素分为不同的 MOA,准确率接近 100%。这些蛋白质倾向于介导多种细菌细胞和代谢过程。在区分不同抗生素时,转录组水平分析与蛋白质表达变化相关性良好。报告的表达特征将有助于未来研究识别未知化合物的 MOA,并促进新型抗生素的发现。